Biomedix Incubator Stock Fundamentals
| BMDX Stock | ILS 19,760 490.00 2.54% |
Biomedix Incubator fundamentals help investors to digest information that contributes to Biomedix Incubator's financial success or failures. It also enables traders to predict the movement of Biomedix Stock. The fundamental analysis module provides a way to measure Biomedix Incubator's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biomedix Incubator stock.
Biomedix |
Biomedix Incubator Company Shares Outstanding Analysis
Biomedix Incubator's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Biomedix Incubator Shares Outstanding | 2.07 M |
Most of Biomedix Incubator's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biomedix Incubator is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Biomedix Incubator has 2.07 M of shares currently outstending. This is much higher than that of the sector and significantly higher than that of the Shares Outstanding industry. The shares outstanding for all Israel stocks is notably lower than that of the firm.
Biomedix Incubator Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biomedix Incubator's current stock value. Our valuation model uses many indicators to compare Biomedix Incubator value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biomedix Incubator competition to find correlations between indicators driving Biomedix Incubator's intrinsic value. More Info.Biomedix Incubator is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biomedix Incubator by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biomedix Incubator's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Biomedix Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biomedix Incubator's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biomedix Incubator could also be used in its relative valuation, which is a method of valuing Biomedix Incubator by comparing valuation metrics of similar companies.Biomedix Incubator is currently under evaluation in shares outstanding category among its peers.
Biomedix Fundamentals
| Return On Equity | -21.76 | |||
| Return On Asset | -14.0 | |||
| Current Valuation | 14.72 M | |||
| Shares Outstanding | 2.07 M | |||
| Price To Earning | (545.45) X | |||
| Price To Book | 361.86 X | |||
| Revenue | 2 K | |||
| Gross Profit | (39 K) | |||
| EBITDA | (1.46 M) | |||
| Net Income | (1.36 M) | |||
| Cash And Equivalents | 5.71 M | |||
| Cash Per Share | 5.10 X | |||
| Current Ratio | 30.06 X | |||
| Book Value Per Share | 4.98 X | |||
| Cash Flow From Operations | (1.62 M) | |||
| Earnings Per Share | (1.10) X | |||
| Beta | 1.21 | |||
| Market Capitalization | 37.28 M | |||
| Total Asset | 9 M | |||
| Retained Earnings | (181 M) | |||
| Working Capital | 9 M | |||
| Current Asset | 9 M | |||
| Z Score | -26.8 |
About Biomedix Incubator Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biomedix Incubator's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomedix Incubator using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomedix Incubator based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Biomedix Incubator Ltd is a venture capital firm and accelerator specializing in start-up and incubation investments. Biomedix Incubator Ltd. was founded in 2000 and is based in Ramat Gan, Israel with an additional office in New York, New York. Biomedix Incubator is traded on Tel Aviv Stock Exchange in Israel.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biomedix Stock
Biomedix Incubator financial ratios help investors to determine whether Biomedix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biomedix with respect to the benefits of owning Biomedix Incubator security.